Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
02/2009
02/26/2009CA2695452A1 Hdac inhibitors
02/25/2009EP2027132A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
02/25/2009EP1694658B1 Method for the production of a thiazolo [3,4,5-de] [4,1]benzothiazepine-type product
02/25/2009CN101374831A Tetrahydropyrane antibiotics
02/24/2009US7495009 Imidazopyridine derivatives as melancortin receptor agonists
02/24/2009US7494991 For microbial infections specially Gram-positive bacterial infection; atherosclerosis-associated disease
02/19/2009WO2009023402A2 Heterocyclic compounds and uses as anticancer agents
02/19/2009WO2009022311A2 1,2-diamido-ethylene derivatives as orexin antagonists
02/19/2009WO2009021990A1 Fused imidazoles for cancer treatment
02/19/2009WO2007095389A3 Treatment of hyperproliferative diseases with camptothecine n-oxide and analogs
02/19/2009US20090048271 Heterocyclic compounds and uses as anticancer agents
02/19/2009US20090048112 Novel Herbicides
02/19/2009CA2695251A1 Fused imidazoles for cancer treatment
02/19/2009CA2694993A1 1,2-diamido-ethylene derivatives
02/19/2009CA2693162A1 Heterocyclic compounds and uses as anticancer agents
02/18/2009EP2025733A1 Material for organic electroluminescence element, and organic electroluminescence element
02/18/2009EP2024365A2 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
02/17/2009US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea
02/17/2009US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease
02/17/2009US7491714 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
02/17/2009CA2400217C Pteridine compounds for the treatment of psoriasis
02/12/2009US20090043097 Methods
02/12/2009US20090042953 IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES
02/12/2009US20090042892 Cetp Inhibitors
02/11/2009EP1605938B1 Antibacterial derivatives of napthydrin and quinoline
02/11/2009EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
02/11/2009CN101365705A Process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2-one
02/10/2009US7488745 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
02/05/2009WO2009018065A2 Novel glucokinase activators and methods of using same
02/05/2009WO2009017822A2 Pi3 kinase modulators and methods of use
02/05/2009WO2009016564A2 2-aza-bicyclo[3.3.0]octane derivatives
02/05/2009WO2009016560A2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
02/05/2009WO2009015897A1 Novel heterocyclic compounds as mglu5 antagonists
02/05/2009WO2008047951A3 An alzheimer' s disease progression inhibitor containing heterocyclic compound
02/05/2009US20090036673 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
02/05/2009CA2694359A1 Novel heterocyclic compounds as mglu5 antagonists
02/05/2009CA2694136A1 Pi3 kinase modulators and methods of use
02/05/2009CA2693820A1 2-aza-bicyclo[3.3.0]octane derivatives
02/05/2009CA2693817A1 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
02/04/2009EP0821589B1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
02/04/2009CN101360748A Inhibitors of c-met and uses thereof
02/04/2009CN100457729C 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives
02/03/2009US7485630 e.g. 2-{[(3'-Amino-1'-aza-2'-oxobicyclo[6.3.0]-undecyl)-11'-carbonyl]amino}-1,5-pentanedioic acid; tripeptide Gly-Pro-Glu (GPE) mimetic; enzymatic degradation, ischemic injury, hypoxic injury, reperfusion injury, and asphyxia
01/2009
01/29/2009WO2009013477A1 Compounds for treating duchenne muscular dystrophy
01/29/2009WO2009012573A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
01/29/2009WO2008063781A3 Chemical compounds as cannabinoid receptor ligands
01/29/2009WO2007114848A3 Chemical compounds
01/29/2009US20090029965 Vasopressin V1a Antagonists
01/29/2009CA2693290A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
01/29/2009CA2685599A1 Compounds for treating duchenne muscular dystrophy
01/28/2009EP2018387A1 Thiazolyldihydroindazoles
01/28/2009EP2018386A1 Thiazolyldihydroindazoles
01/28/2009EP2018385A1 Thiazolyl-dihydroquinazolines
01/28/2009CN101356178A Compounds and compositions as PPAR modulators
01/28/2009CN101356149A Indene derivatives, their preparation and use as medicaments
01/28/2009CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
01/27/2009US7482456 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
01/27/2009US7482452 intermediates for p38 MAP kinase inhibitors; industrial scale; 3-cyano-6-oxo-2-thio-1,6-dihydropyridines or pyrimidine, 2,4-diones as starting reactants and 2-cyano-N-phenylthioacetamide; cyclization; diazotization of 3-amino-7H-thieno[2,3-b]pyridin-6-ones, halide displacement
01/27/2009US7482338 Non-amide nonanes
01/27/2009CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
01/22/2009WO2009011851A1 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
01/22/2009WO2009010925A2 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof
01/22/2009WO2009010785A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections
01/22/2009WO2009010783A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections
01/22/2009WO2009010694A2 Dyeing method using a styryl- or imine-type disulfide/thiol compound and stimuli, composition and device for implementing same
01/22/2009WO2008111018A9 Process for the preparation of crystals of prulifloxacin
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009CA2693537A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections
01/22/2009CA2693533A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections
01/22/2009CA2693216A1 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
01/21/2009CN101348496A S-triazolothiadiazole compound, and preparation and use thereof
01/21/2009CN101348495A Thiazolo-[3,2-a] pyridine compound and use thereof as Bcl-2 family protein antagonist
01/15/2009WO2008119734A3 Process for the manufacture of organic compounds
01/15/2009US20090018056 Heteroarylcarbamoylbenzene derivatives
01/14/2009EP2013218A2 Raf inhibitors and their uses
01/14/2009CN101346386A Process for the preparation of S-(+)-clopidogrel by optical resolution
01/14/2009CN101346383A 三唑衍生物 Triazole derivatives
01/13/2009US7476668 Thiadiazine derivatives and use thereof as positive AMPA receptor modulators
01/13/2009CA2440186C Medicinal composition containing 1,3-thiazine derivative
01/08/2009WO2009004584A1 3-aza-bicyclo[3.3.0]octane compounds
01/08/2009US20090012068 Condensed Imidazole Derivatives as Aldosterone Synthase Inhibitors
01/08/2009US20090011975 Targeted bone marrow protection agents
01/08/2009CA2691373A1 3-aza-bicyclo[3.3.0]octane compounds
01/07/2009EP2010540A1 Spiro-imidazo compounds
01/07/2009EP2010532A1 Tryclic nitrogen containing compounds and their use as antibacterials
01/07/2009EP1858900B1 Fused thiazole derivatives having affinity for the histamine h3 receptor
01/07/2009EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases
01/07/2009CN100448880C 2'oxo-voruscharin and derivatives thereof
01/07/2009CN100448444C Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
01/06/2009US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
01/06/2009US7473783 Bicyclic pyrazolo protein kinase modulators
01/06/2009US7473691 Pyrazole compounds useful as protein kinase inhibitors
01/01/2009US20090005417 Substituted Indazolyl Sulfonamide and 2,3-Dihydro-Indolyl Sulfonamide Compounds, their Preparation and Use in Medicaments
01/01/2009US20090005399 Substituted Imidazo[2,1-b]thiazole Compounds and Uses Thereof
01/01/2009US20090005373 Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
01/01/2009US20090005368 such as 6-({trans-4-[(1R)-1-hydroxy-2-(3-methoxy-quinolin-5-yl)-ethyl]-cyclohexylamino}-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one for treating infections from Streptococcus pneumoniae, Haemophilus influenzae, Moraxella, Staphylococcus, Enterococcus
12/2008
12/31/2008WO2009001214A2 Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
12/31/2008WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors
12/31/2008WO2009001089A1 Fused thiazole derivatives as kinase inhibitors
12/31/2008WO2008117241A3 Thiazolidine derivatives as orexin receptor antagonists
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 152